JAMP PRASUGREL

Product Overview

About JAMP PRASUGREL

JAMP PRASUGREL is a medication that contains the active ingredient PRASUGREL (PRASUGREL HYDROCHLORIDE), which belongs to the class of antiplatelet agents. It is primarily used to prevent blood clots in patients with acute coronary syndrome (ACS) who are undergoing percutaneous coronary intervention (PCI). JAMP PRASUGREL works by inhibiting platelet activation and aggregation, thereby reducing the risk of myocardial infarction and stroke.

Key Benefits & Uses

• Prevention of blood clots in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI)
• Reduction of the risk of myocardial infarction and stroke in patients with ACS
• Inhibition of platelet activation and aggregation, which can help to prevent thrombotic complications

Active Ingredient & Action

PRASUGREL (PRASUGREL HYDROCHLORIDE) is a prodrug that is metabolized to its active metabolite, which then binds to the P2Y12 receptor on platelets, inhibiting adenosine diphosphate (ADP)-mediated platelet activation and aggregation. This action helps to prevent the formation of blood clots and reduce the risk of thrombotic events.

Important Notes

Patients taking JAMP PRASUGREL should be monitored for signs of bleeding, as it can increase the risk of bleeding complications. It is also important to follow the prescribed dosage and administration instructions carefully, and to inform your doctor about any other medications you are taking, as they may interact with JAMP PRASUGREL. If you experience any symptoms of bleeding or other adverse effects, seek medical attention immediately.